Search

Your search keyword '"Chang, Wesley"' showing total 220 results

Search Constraints

Start Over You searched for: Author "Chang, Wesley" Remove constraint Author: "Chang, Wesley"
220 results on '"Chang, Wesley"'

Search Results

3. Evolving contact mechanics and microstructure formation dynamics of the lithium metal-Li7La3Zr2O12 interface.

6. Aligning lithium metal battery research and development across academia and industry

7. Rack shadows and their invariants

8. Relating Chemo-Mechanical Hysteresis and Formation Protocols for Anode-Free Lithium Metal Batteries.

11. Fluorescent Nanodiamonds

12. Physical Models Have Gender-Specific Effects on Student Understanding of Protein Structure-Function Relationships

13. Supplementary Figure Legends and Supplementary Table. from AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma

14. Data from AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma

15. Supplementary Figure S1 from AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma

16. Data from SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

17. Data from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

18. Supplementary Figure 1 from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

19. Supplementary Methods from SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

20. Supplementary Figures S1-S6 from SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

21. Supplementary Table 1 from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

22. Supplementary Figure Legend from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

23. Supplementary Tables S1-S2 from SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

41. A Titin mutation defines roles for circulation in endothelial morphogenesis

48. Evolving contact mechanics and microstructure formation dynamics of the lithium metal-Li7La3Zr2O12 interface.

Catalog

Books, media, physical & digital resources